Skip to the page

Data / Drug companies / Clinical Resolution Laboratory, Inc.

Clinical Resolution Laboratory, Inc.: 10 products in the FDA NDC directory, labeler code 63742

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Clinical Resolution Laboratory, Inc. (labeler code 63742) lists 10 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 6, 2025.

The request: Watch Clinical Resolution Laboratory, Inc. (FDA labeler code 63742): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
63742
Products in commercial distribution
10
Packages
16
Finished drugs by generic name
6
Prescription products
0
Over the counter products
10
Flagged as original packager
10 of 10 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
October 4, 2018
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs10100%

Products by type

TypeProductsShare
Over the counter drugs10100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lidocaine5216
Lidocaine , phenylephrine hcl11
Menthol1263
Miconazole nitrate1101
Lidocaine, phenylephrine hydrochloride17
Lidocaine, phenylephrine hcl13

Dosage forms

Dosage formProductsShare
Cream770%
Lotion110%
Spray110%
Ointment110%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Fungus Master63742-098LotionOver the counter monograph drugsJune 6, 2025
Quick Numb63742-333CreamOver the counter monograph drugsMay 14, 2025
Numb 52063742-027CreamOver the counter monograph drugsApril 7, 2025
Liposomal Hemorrhoid Master63742-038CreamOver the counter monograph drugsAugust 28, 2024
Numb52063742-033CreamOver the counter monograph drugsNovember 1, 2021
Numb Master63742-032CreamOver the counter monograph drugsNovember 1, 2021
Hemorrhoid Master63742-045OintmentOver the counter monograph drugsNovember 1, 2019
Lightning Pain Relief63742-013CreamOver the counter monograph drugsMay 1, 2019
Numb52063742-034SprayOver the counter monograph drugsNovember 26, 2018
Numb2563742-035CreamOver the counter monograph drugsOctober 4, 2018

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.